3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-1-ol
CAS No.:
1000802-50-5
M. Wt:
252.11800
M. Fa:
C12H21BN2O3
InChI Key:
ZVUJZEKDRFLYFL-UHFFFAOYSA-N
Appearance:
Yellow Liquid
Names and Identifiers of 1000802-50-5
CAS Number |
1000802-50-5 |
|---|---|
MDL Number |
MFCD22570729 |
IUPAC Name |
3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propan-1-ol |
InChI |
InChI=1S/C12H21BN2O3/c1-11(2)12(3,4)18-13(17-11)10-8-14-15(9-10)6-5-7-16/h8-9,16H,5-7H2,1-4H3 |
InChIKey |
ZVUJZEKDRFLYFL-UHFFFAOYSA-N |
Canonical SMILES |
B1(OC(C(O1)(C)C)(C)C)C2=CN(N=C2)CCCO |
UNSPSC Code |
12352100 |
Physical and chemical properties of 1000802-50-5
Acidity coefficient |
14.91±0.10(Predicted) |
|---|---|
Boiling Point |
400.6±25.0 °C(Predicted) |
Density |
1.11±0.1 g/cm3(Predicted) |
Exact Mass |
252.16500 |
LogP |
0.56470 |
Molecular Formula |
C12H21BN2O3 |
Molecular Weight |
252.11800 |
PSA |
56.51000 |
Safety Information of 1000802-50-5
Applications of 1000802-50-5
This compound has several potential applications:
- Organic Synthesis: It serves as an intermediate in synthesizing various organic compounds through coupling reactions.
- Medicinal Chemistry: Its derivatives may lead to new pharmacological agents with antitumor properties.
- Material Science: The unique properties of boron-containing compounds make them suitable for developing novel materials and polymers.
Interaction Studies of 1000802-50-5
Interaction studies involving 3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-1-ol focus on its reactivity and binding affinity with biological targets.
Key Findings:- Binding Affinity: Studies indicate that compounds with similar structures can exhibit varying degrees of binding affinity towards specific enzymes or receptors.
- Mechanism of Action: The mechanism often involves borylation processes that modify biological molecules and pathways.
Biological Activity of 1000802-50-5
Compounds similar to 3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-1-ol have shown significant biological activity. For instance:
- Antitumor Activity: Some derivatives are known to be key intermediates in synthesizing biologically active compounds like crizotinib, which is used in cancer treatment.
- Enzyme Inhibition: The compound may interact with specific enzymes or receptors due to its structural features, potentially leading to inhibitory effects on certain biological pathways.
